Publications by authors named "Thomas Strub"

Claim this Profile
S
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target.
Imène Krossa, Céline Pisibon, Yann Cheli, Karine Bille, Mélanie Dalmasso, Thomas Strub

Cell Death Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Sarah Proteau, Imène Krossa, Chrystel Husser, Maxime Guéguinou, Federica Sella, Thomas Strub

EMBO Mol Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Sarah Proteau, Imène Krossa, Chrystel Husser, Maxime Guéguinou, Federica Sella, Thomas Strub

EMBO Mol Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
Imène Krossa, Thomas Strub, Andrew E Aplin, Robert Ballotti, Corine Bertolotto

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in understanding the role of HES6 in cancers.
Imène Krossa, Thomas Strub, Arnaud Martel, Sacha Nahon-Esteve, Sandra Lassalle

Theranostics· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance.
Maria Chiara Gelmi, Laurien E Houtzagers, Thomas Strub, Imène Krossa, Martine J Jager

Int J Mol Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology.
Thomas Strub, Arnaud Martel, Sacha Nahon-Esteve, Stéphanie Baillif, Robert Ballotti

Prog Retin Eye Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease.
Charlotte Pandiani, Thomas Strub, Nicolas Nottet, Yann Cheli, Giovanni Gambi

Cell Death Differ· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies".
Thomas Strub, Robert Ballotti, Corine Bertolotto

Theranostics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
Yann Cheli, Meri K Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Thomas Strub

Mol Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
Yann Cheli, Meri K Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Thomas Strub

Mol Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution.
Pakavarin Louphrasitthiphol, Robert Siddaway, Alessia Loffreda, Vivian Pogenberg, Hans Friedrichsen, Thomas Strub

Mol Cell· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells.
Lara Bellini, Thomas Strub, Nadia Habel, Charlotte Pandiani, Sandrine Marchetti

Cell Death Discov· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIRT6 haploinsufficiency induces BRAF melanoma cell resistance to MAPK inhibitors via IGF signalling.
Thomas Strub, Flavia G Ghiraldini, Saul Carcamo, Man Li, Aleksandra Wroblewska

Nat Commun· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
Caroline Bonet, Flavie Luciani, Jean-François Ottavi, Justine Leclerc, Fanélie-Marie Jouenne, Thomas Strub

J Natl Cancer Inst· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy

Nature· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells.
Dana Koludrovic, Patrick Laurette, Thomas Strub, Céline Keime, Madeleine Le Coz

PLoS Genet· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma.
Chiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, Sebastian Pünzeler, David Valle-Garcia, Thomas Strub

Mol Cell· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
Patrick Laurette, Thomas Strub, Dana Koludrovic, Céline Keime, Stéphanie Le Gras

Elife· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy

Nature· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 is a new MITF target gene.
Laurent Beuret, Mickael Ohanna, Thomas Strub, Maryline Allegra, Irwin Davidson

Pigment Cell Melanoma Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis